Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Scientists build ‘microfish’ robots for controlled drug delivery

US researchers say 3-D printed microscopic fish robots will allow intelligent drug delivery.

MHRA uncovers $1m illegal ED drug haul

A UK man has been sentenced to 16 months in prison for smuggling illegal erectile dysfunction drugs following an MHRA investigation.

To supply the Dane: Novo expects First API batch in 2020

Novo Nordisk has confirmed it will build an API plant in the US, telling this publication a desire to have manufacturing capacity in the key market drove the decision.

Europe, US, Japan: The recall round-up

Product problems for Allergan and Danish Leo Pharma, plus the Japanese regulator reviews a Bristol-Myers Squibb mAb.

MHLW urges Japan's generics sector to consolidate

The Japanese Government says consolidation of the country’s generics sector is needed to secure supplies.

Device advice: Intertek study shows its key to consider devices in formulation development

Pharma firms developing inhalable drugs often fail to test that their formulations are compatible with their intended delivery devices early enough according to Intertek.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...